Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0JC4Q
|
||||
| Former ID |
DNC013018
|
||||
| Drug Name |
4-(4-chlorobenzyl)-2-allylphthalazin-1(2H)-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528062] | ||
| Formula |
C18H15ClN2O
|
||||
| Canonical SMILES |
C=CCN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=C(C=C3)Cl
|
||||
| InChI |
1S/C18H15ClN2O/c1-2-11-21-18(22)16-6-4-3-5-15(16)17(20-21)12-13-7-9-14(19)10-8-13/h2-10H,1,11-12H2
|
||||
| InChIKey |
OHEWOPKEAKDVRX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-1A adrenergic receptor | Target Info | Inhibitor | [528062] | |
| Alpha-1D adrenergic receptor | Target Info | Inhibitor | [528062] | ||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
| References | |||||